3 Biotech Stocks Wall Street Expects to Double Soon
If you're looking for stocks that can make big moves in a small amount of time, the biotech industry has plenty to choose from. Clinical trial readouts, Food and Drug Administration decisions, and new-drug launch trajectories can cause small-cap biotech stocks to shoot higher, or collapse, overnight.
All three of these companies are working on new drugs that could be worth a mint, according to Wall Street. Read on to see why their stock prices don't match up with analyst expectations.
Image source: Getty Images.
Source Fool.com
